Literature DB >> 24307622

CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.

G G Sun1, J Zhang, W N Hu.   

Abstract

This study aimed to analyze the expression, clinical significance of cyclin G2 (CCNG2) in colorectal carcinoma, and the biological effect in its cell line by CCNG2 overexpression. Immunohistochemistry and Western blot were used to analyze CCNG2 protein expression in colorectal cancer and to study the influence of the upregulated expression of CCNG2 that might be found on SW480 cell biological effect. We found that the level of CCNG2 protein expression was significantly lower in colorectal cancer tissue than normal tissues (P < 0.05). The level of CCNG2 was correlated with T stages, lymph node metastasis, clinic stage, and histological grade (P < 0.05). Loss of CCNG2 expression correlated significantly with poor overall survival time by Kaplan-Meier analysis (P < 0.05). The result of biological function has shown that SW480 cell-transfected CCNG2 had a lower survival fraction, higher percentage of the G0/G1 phases, and lower CDK2 protein expression compared with SW480 cell-untransfected CCNG2 (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24307622     DOI: 10.1007/s13277-013-1440-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

1.  Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest.

Authors:  M C Horne; K L Donaldson; G L Goolsby; D Tran; M Mulheisen; J W Hell; A F Wahl
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

2.  Mean number of lymph nodes in colonic cancer specimen: possible quality control index for surgical performance.

Authors:  G Dimofte; E Târcoveanu; M Taraşi; C Panait; G Lozneanu; S Nicolescu; V Porumb; O Grigoraş
Journal:  Chirurgia (Bucur)       Date:  2011 Nov-Dec

3.  FOXA1 is essential for aryl hydrocarbon receptor-dependent regulation of cyclin G2.

Authors:  Shaimaa Ahmed; Sarra Al-Saigh; Jason Matthews
Journal:  Mol Cancer Res       Date:  2012-05       Impact factor: 5.852

4.  Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.

Authors:  Aruni S Arachchige Don; Robert F Dallapiazza; David A Bennin; Tiffany Brake; Colleen E Cowan; Mary C Horne
Journal:  Exp Cell Res       Date:  2006-09-29       Impact factor: 3.905

5.  Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression.

Authors:  M C Horne; G L Goolsby; K L Donaldson; D Tran; M Neubauer; A F Wahl
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

6.  Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest.

Authors:  David A Bennin; Aruni S Arachchige Don; Tiffany Brake; Jennifer L McKenzie; Heidi Rosenbaum; Linette Ortiz; Anna A DePaoli-Roach; Mary C Horne
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

7.  Cyclin G2 dysregulation in human oral cancer.

Authors:  Yong Kim; Satoru Shintani; Yohko Kohno; Rong Zhang; David T Wong
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

8.  Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.

Authors:  Guoxiong Xu; Stefanie Bernaudo; Guodong Fu; Daniel Y Lee; Burton B Yang; Chun Peng
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

9.  Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN.

Authors:  Cristina Cellai; Anna Laurenzana; Elisa Bianchi; Sara Sdelci; Rossella Manfredini; Alessandro M Vannucchi; Roberto Caporale; Manjola Balliu; Francesco Mannelli; Sergio Ferrari; Alberto Bosi; Debora Miniati; Pier L Cocco; Steeve Veronneau; Jana Stankova; Francesco Paoletti
Journal:  Exp Hematol       Date:  2009-07-15       Impact factor: 3.084

Review 10.  Prognostic and predictive factors in colorectal cancer.

Authors:  A Bolocan; D Ion; D N Ciocan; D N Paduraru
Journal:  Chirurgia (Bucur)       Date:  2012 Sep-Oct
View more
  6 in total

1.  The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.

Authors:  L Mourgues; V Imbert; M Nebout; P Colosetti; Z Neffati; P Lagadec; E Verhoeyen; C Peng; E Duprez; L Legros; N Rochet; V Maguer-Satta; F-E Nicolini; D Mary; J-F Peyron
Journal:  Leukemia       Date:  2015-04-30       Impact factor: 11.528

2.  Cyclin G2: A novel independent prognostic marker in pancreatic cancer.

Authors:  Shinichiro Hasegawa; Hiroaki Nagano; Masamitsu Konno; Hidetoshi Eguchi; Akira Tomokuni; Yoshito Tomimaru; Hiroshi Wada; Naoki Hama; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Naohiro Nishida; Jun Koseki; Noriko Gotoh; Shouichi Ohno; Norikazu Yabuta; Hiroshi Nojima; Masaki Mori; Yuichiro Doki; Hideshi Ishii
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

3.  Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice.

Authors:  Liang Chi; Jingchuan Xue; Pengcheng Tu; Yunjia Lai; Hongyu Ru; Kun Lu
Journal:  Arch Toxicol       Date:  2018-10-24       Impact factor: 5.153

4.  MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer.

Authors:  S Hasegawa; H Eguchi; H Nagano; M Konno; Y Tomimaru; H Wada; N Hama; K Kawamoto; S Kobayashi; N Nishida; J Koseki; T Nishimura; N Gotoh; S Ohno; N Yabuta; H Nojima; M Mori; Y Doki; H Ishii
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

5.  Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.

Authors:  Verónica Cánovas; Yolanda Puñal; Valentina Maggio; Enric Redondo; Mercedes Marín; Begoña Mellado; Mireia Olivan; Matilde Lleonart; Jacques Planas; Juan Morote; Rosanna Paciucci
Journal:  Oncotarget       Date:  2017-07-22

6.  Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancer.

Authors:  Hongyou Zhao; Bin Yi; Zhipin Liang; Ches'Nique Phillips; Hui-Yi Lin; Adam I Riker; Yaguang Xi
Journal:  Genes Dis       Date:  2020-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.